11 – 17 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2007
-
Mark
Nutritional aspects in patients with functional gastrointestinal disorders and motor dysfunction in the gut. Working team report of the Swedish Motility Group (SMoG)
(
- Contribution to journal › Article
-
Mark
Endotoxin- and D-galactosamine-induced liver injury improved by the administration of Lactobacillus, Bifidobacterium and blueberry
(
- Contribution to journal › Article
-
Mark
Factors associated with the technical performance of colonoscopy: An EPAGE study.
(
- Contribution to journal › Article
- 2006
-
Mark
Serum antibodies to enterohepatic Helicobacter spp. in patients with chronic liver diseases and in a population with high prevalence of H-pylori infection
(
- Contribution to journal › Article
- 2005
-
Mark
Microbes as trigger for primary biliary cirrhosis and primary sclerosing cholangitis.
(
- Contribution to journal › Letter
- 2002
-
Mark
Early treatment with lexipafant, a platelet-activating factor-receptor antagonist, is not sufficient to prevent pulmonary endothelial damage after intestinal ischaemia and reperfusion in rats.
(
- Contribution to journal › Article
-
Mark
Gut barrier permeability, reticuloendothelial system function and protease inhibitor levels following intestinal ischaemia and reperfusion--effects of pretreatment with N-acetyl-L-cysteine and indomethacin.
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »